SCD and cancer: With predominantly tumor-promoting properties, SCD1 has been noted to be upregulated in multiple cancers, including lung adenocarcininoma (Huang et al., 2016), hepatocellular carcinoma (Huang et al., 2015), and clear cell renal carcinoma (von Roemeling et al., 2013).